Intuitive Surgical, Inc. Deferred Tax Expense from Stock Options Exercised
Intuitive Surgical, Inc. (ISRG) reported Deferred Tax Expense from Stock Options Exercised of $0 for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-04.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:DeferredTaxExpenseFromStockOptionsExercised · last filed 2019-02-04
- Intuitive Surgical, Inc. deferred tax expense from stock options exercised for the quarter ending 2017-12-31 was $0.00, a 100.00% decline year-over-year.
- Intuitive Surgical, Inc. deferred tax expense from stock options exercised for the quarter ending 2017-09-30 was $0.00, a 100.00% decline year-over-year.
- Intuitive Surgical, Inc. deferred tax expense from stock options exercised for the quarter ending 2017-06-30 was $0.00, a 100.00% decline year-over-year.
- Intuitive Surgical, Inc. deferred tax expense from stock options exercised for the quarter ending 2017-03-31 was $0.00, a 100.00% decline year-over-year.
- Intuitive Surgical, Inc. deferred tax expense from stock options exercised for fiscal 2018 was $0.00.
- Intuitive Surgical, Inc. deferred tax expense from stock options exercised for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- Intuitive Surgical, Inc. deferred tax expense from stock options exercised for fiscal 2016 was $29.80M, a 38.60% increase from fiscal 2015.
- Intuitive Surgical, Inc. deferred tax expense from stock options exercised for fiscal 2015 was $21.50M, a 54.68% increase from fiscal 2014.
| Period end | Deferred Tax Expense from Stock Options Exercised 3 month | Deferred Tax Expense from Stock Options Exercised 6 month | Deferred Tax Expense from Stock Options Exercised 9 month | Deferred Tax Expense from Stock Options Exercised 12 month |
|---|---|---|---|---|
| 2018-12-31 | $0.00 10-K · filed 2019-02-04 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-04 | $0.00 derived: sum of 2 quarters · filed 2019-02-04 | $0.00 derived: sum of 3 quarters · filed 2019-02-04 | $0.00 10-K · filed 2019-02-04 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-20 | $0.00 derived: sum of 2 quarters · filed 2017-10-20 | $0.00 10-Q · filed 2017-10-20 | $4.20M derived: sum of 4 quarters · filed 2019-02-04 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-21 | $0.00 10-Q · filed 2017-07-21 | $4.20M derived: sum of 3 quarters · filed 2019-02-04 | $11.50M derived: sum of 4 quarters · filed 2019-02-04 |
| 2017-03-31 | $0.00 10-Q · filed 2017-04-19 | $4.20M derived: sum of 2 quarters · filed 2019-02-04 | $11.50M derived: sum of 3 quarters · filed 2019-02-04 | $19.00M derived: sum of 4 quarters · filed 2019-02-04 |
| 2016-12-31 | $4.20M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-04 | $11.50M derived: sum of 2 quarters · filed 2019-02-04 | $19.00M derived: sum of 3 quarters · filed 2019-02-04 | $29.80M 10-K · filed 2019-02-04 |
| 2016-09-30 | $7.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-20 | $14.80M derived: sum of 2 quarters · filed 2017-10-20 | $25.60M 10-Q · filed 2017-10-20 | $22.90M derived: sum of 4 quarters · filed 2018-02-02 |
| 2016-06-30 | $7.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-21 | $18.30M 10-Q · filed 2017-07-21 | $15.60M derived: sum of 3 quarters · filed 2018-02-02 | $22.50M derived: sum of 4 quarters · filed 2018-02-02 |
| 2016-03-31 | $10.80M 10-Q · filed 2017-04-19 | $8.10M derived: sum of 2 quarters · filed 2018-02-02 | $15.00M derived: sum of 3 quarters · filed 2018-02-02 | $24.10M derived: sum of 4 quarters · filed 2018-02-02 |
| 2015-12-31 | -$2.70M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-02 | $4.20M derived: sum of 2 quarters · filed 2018-02-02 | $13.30M derived: sum of 3 quarters · filed 2018-02-02 | $21.50M 10-K · filed 2018-02-02 |
| 2015-09-30 | $6.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-19 | $16.00M derived: sum of 2 quarters · filed 2016-10-19 | $24.20M 10-Q · filed 2016-10-19 | $30.40M derived: sum of 4 quarters · filed 2017-02-06 |
| 2015-06-30 | $9.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-20 | $17.30M 10-Q · filed 2016-07-20 | $23.50M derived: sum of 3 quarters · filed 2017-02-06 | $30.30M derived: sum of 4 quarters · filed 2017-02-06 |
| 2015-03-31 | $8.20M 10-Q · filed 2016-04-19 | $14.40M derived: sum of 2 quarters · filed 2017-02-06 | $21.20M derived: sum of 3 quarters · filed 2017-02-06 | $20.00M derived: sum of 4 quarters · filed 2017-02-06 |
| 2014-12-31 | $6.20M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-06 | $13.00M derived: sum of 2 quarters · filed 2017-02-06 | $11.80M derived: sum of 3 quarters · filed 2017-02-06 | $13.90M 10-K · filed 2017-02-06 |
| 2014-09-30 | $6.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-21 | $5.60M derived: sum of 2 quarters · filed 2015-10-21 | $7.70M 10-Q · filed 2015-10-21 | $12.50M derived: sum of 4 quarters · filed 2016-02-02 |
| 2014-06-30 | -$1.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-22 | $900.00K 10-Q · filed 2015-07-22 | $5.70M derived: sum of 3 quarters · filed 2016-02-02 | $9.60M derived: sum of 4 quarters · filed 2016-02-02 |
| 2014-03-31 | $2.10M 10-Q · filed 2015-04-22 | $6.90M derived: sum of 2 quarters · filed 2016-02-02 | $10.80M derived: sum of 3 quarters · filed 2016-02-02 | $16.70M derived: sum of 4 quarters · filed 2016-02-02 |
| 2013-12-31 | $4.80M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-02 | $8.70M derived: sum of 2 quarters · filed 2016-02-02 | $14.60M derived: sum of 3 quarters · filed 2016-02-02 | $34.50M 10-K · filed 2016-02-02 |
| 2013-09-30 | $3.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-23 | $9.80M derived: sum of 2 quarters · filed 2014-10-23 | $29.70M 10-Q · filed 2014-10-23 | $68.80M derived: sum of 4 quarters · filed 2015-02-06 |
| 2013-06-30 | $5.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-24 | $25.80M 10-Q · filed 2014-07-24 | $64.90M derived: sum of 3 quarters · filed 2015-02-06 | |
| 2013-03-31 | $19.90M 10-Q · filed 2014-04-25 | $59.00M derived: sum of 2 quarters · filed 2015-02-06 | ||
| 2012-12-31 | $39.10M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-06 | $93.90M 10-K · filed 2015-02-06 | ||
| 2012-09-30 | $54.80M 10-Q · filed 2013-10-18 | |||
| 2011-12-31 | $48.60M 10-K · filed 2014-02-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Edwards Lifesciences Corp (EW) | United States | $49.409B | 51.96 |
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |